Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Schabath, Matthew B ^a   Massion, Pierre P ^b   Thompson, Zachary J ^a   Eschrich, Steven A ^a   Balagurunathan, Yoganand ^a   Goldof, Dmitry ^c   Aberle, Denise R ^d   Gillies, Robert J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c University of South Florida   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INTERVAL LUNG CANCER; KAPLAN MEIER METHOD; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OVERALL SURVIVAL; PREVALENCE; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; DEMOGRAPHY; DISEASE FREE SURVIVAL; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK; SMOKING; X-RAY COMPUTED TOMOGRAPHY;

AGED; DEMOGRAPHY; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84983422705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0159880     Document Type: Article

References (20)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. Epub 2011/07/01. doi: 10.1056/NEJMoa1102873 PMID: 21714641.
2. Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, et al. Baseline characteristics of participants in the randomized national lung screening trial. Journal of the National Cancer Institute. 2010; 102(23):1771-9. doi: 10.1093/jnci/djq434 PMID: 21119104
3. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, et al. The National Lung Screening Trial: overview and study design. Radiology. 2011; 258(1):243-53. Epub 2010/11/04. doi: 10.1148/ radiol.10091808 PMID: 21045183; PubMed Central PMCID: PMC3009383.
4. Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer. 2007; 56 (2):193-9. Epub 2007/01/24. doi: 10.1016/j.lungcan.2006.12.001 PMID: 17239983.
5. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999; 354 (9173):99-105. Epub 1999/07/17. doi: 10.1016/S0140-6736(99)06093-6 PMID: 10408484.
6. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 2008; 178(9):956-61. Epub 2008/07/19. doi: 10.1164/rccm.200802-336OC PMID: 18635890; PubMed Central PMCID: PMC2720144.
7. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013; 369(10):920-31. Epub 2013/09/ 06. doi: 10.1056/NEJMoa1208962 PMID: 24004119.
8. Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013; 368(21):1980-91. Epub 2013/05/ 24. doi: 10.1056/NEJMoa1209120 PMID: 23697514; PubMed Central PMCID: PMC3762603.
9. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, et al. Screening for lung cancer. Cochrane Database Syst Rev. 2013; doi: 10.1002/14651858.CD001991.pub3. Epub 2013/06/25. PMID: 23794187.
10. Patz EF Jr., Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, et al. Overdiagnosis in lowdose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174(2):269-74. Epub 2013/12/11. doi: 10.1001/jamainternmed.2013.12738 PMID: 24322569.
11. National Cancer Institute (NCI) Cancer Data Access System (CDAS). URL at: https://biometry.nci.nih. gov/cdas/.
12. Patz EF Jr., Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol. 2016. doi: 10.1016/S1470-2045(15)00621-X PMID: 27009070.
13. Veronesi G, Maisonneuve P, Rampinelli C, Bertolotti R, Petrella F, Spaggiari L, et al. Computed tomography screening for lung cancer: Results of ten years of annual screening and validation of cosmos prediction model. Lung Cancer. 2013; 82(3):426-30. Epub 2013/10/09. doi: 10.1016/j.lungcan.2013.08. 026 PMID: 24099665.
14. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355(17):1763-71. Epub 2006/ 10/27. doi: 10.1056/NEJMoa060476 PMID: 17065637.
15. Kondo R, Yoshida K, Kawakami S, Shiina T, Kurai M, Takasuna K, et al. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen. Lung Cancer. 2011; 74(3):433-40. Epub 2011/06/15. doi: 10.1016/j.lungcan. 2011.05.007 PMID: 21663995.
16. Padda SK, Burt BM, Trakul N, Wakelee HA. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014; 41(1):40-56. Epub 2014/02/ 26. doi: 10.1053/j.seminoncol.2013.12.011 PMID: 24565580.
17. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):e278S-313S. Epub 2013/05/10. doi: 10.1378/chest.12-2359 PMID: 23649443.
18. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila). 2012; 5(8):992-1006. Epub 2012/06/13. doi: 10.1158/1940-6207.CAPR-11-0441 PMID: 22689914; PubMed Central PMCID: PMC3723112.
19. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012; 48(4):441-6. Epub 2012/01/20. doi: 10.1016/j.ejca.2011.11.036 PMID: 22257792.
20. Schabath MB, Massion PP, Thompson ZJ, Eschrich SA, Balagurunathan Y, Goldof D, et al. Behavior Differences of Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial (NLST). J Thorac Oncol. 2015; 10(9):S221-S. WOS:000370365100350.